Matches in Wikidata for { <http://www.wikidata.org/entity/Q57617348> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q57617348 description "article scientifique publié en 2010" @default.
- Q57617348 description "article" @default.
- Q57617348 description "im Dezember 2010 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57617348 description "wetenschappelijk artikel" @default.
- Q57617348 description "наукова стаття, опублікована в грудні 2010" @default.
- Q57617348 description "հոդված" @default.
- Q57617348 name "Development of PEGylated doxorubicin-E-[c" @default.
- Q57617348 name "Development of PEGylated doxorubicin-E-[c(RGDfK)2] conjugate for integrin-targeted cancer therapy" @default.
- Q57617348 type Item @default.
- Q57617348 label "Development of PEGylated doxorubicin-E-[c" @default.
- Q57617348 label "Development of PEGylated doxorubicin-E-[c(RGDfK)2] conjugate for integrin-targeted cancer therapy" @default.
- Q57617348 prefLabel "Development of PEGylated doxorubicin-E-[c" @default.
- Q57617348 prefLabel "Development of PEGylated doxorubicin-E-[c(RGDfK)2] conjugate for integrin-targeted cancer therapy" @default.
- Q57617348 P1433 Q57617348-FC7F1354-D840-4221-8891-BE0DAE4C5B55 @default.
- Q57617348 P1476 Q57617348-123F804C-F763-4F79-B0FE-85C6EB2D52D1 @default.
- Q57617348 P2093 Q57617348-399D37CA-7FEF-4C18-8781-FE3F7CD18872 @default.
- Q57617348 P2093 Q57617348-541DD594-AF42-4E1C-9D47-D454F12FF3EA @default.
- Q57617348 P2093 Q57617348-64F145BC-B27F-482D-BA4A-037F267D1A7A @default.
- Q57617348 P2093 Q57617348-92B24E40-793B-41F1-BB4A-B5A5F6F88DF0 @default.
- Q57617348 P2093 Q57617348-D807A5DD-80A2-454D-B34F-B305BE2BC739 @default.
- Q57617348 P2093 Q57617348-D8A48E78-4506-4FC2-ACC8-DA46F018A308 @default.
- Q57617348 P2860 Q57617348-3246FC56-5371-4591-80E4-BF6B5D88505E @default.
- Q57617348 P2860 Q57617348-AFF2A909-A1C6-4087-BE14-2DA94637D029 @default.
- Q57617348 P304 Q57617348-CD86802B-85C3-43C2-B548-1831ADC32F6B @default.
- Q57617348 P31 Q57617348-CE9A95EF-1430-4ADD-B318-CC1CEE241626 @default.
- Q57617348 P356 Q57617348-FD86FCED-2269-4E5D-BFB1-A79436695A9B @default.
- Q57617348 P433 Q57617348-0F7CB069-8CB4-4E90-B2F8-CD79406F2127 @default.
- Q57617348 P478 Q57617348-ECE25823-7308-4245-9658-7DF2A4D18A60 @default.
- Q57617348 P50 Q57617348-90711B63-79BA-4F7B-BE42-1574CE404AC3 @default.
- Q57617348 P50 Q57617348-D70C2C5F-2DED-4AB5-9517-8B4F00986BCC @default.
- Q57617348 P577 Q57617348-80038154-E534-4C65-B830-EAAB907F5D01 @default.
- Q57617348 P356 PAT.1731 @default.
- Q57617348 P1433 Q3004145 @default.
- Q57617348 P1476 "Development of PEGylated doxorubicin-E-[c(RGDfK)2] conjugate for integrin-targeted cancer therapy" @default.
- Q57617348 P2093 "Anat Eldar-Boock" @default.
- Q57617348 P2093 "Ariel Many" @default.
- Q57617348 P2093 "Claudia Ryppa" @default.
- Q57617348 P2093 "Dina Polyak" @default.
- Q57617348 P2093 "Felix Kratz" @default.
- Q57617348 P2093 "Kai Licha" @default.
- Q57617348 P2860 Q34603045 @default.
- Q57617348 P2860 Q35992199 @default.
- Q57617348 P304 "103-113" @default.
- Q57617348 P31 Q13442814 @default.
- Q57617348 P356 "10.1002/PAT.1731" @default.
- Q57617348 P433 "1" @default.
- Q57617348 P478 "22" @default.
- Q57617348 P50 Q19758708 @default.
- Q57617348 P50 Q55112177 @default.
- Q57617348 P577 "2010-12-28T00:00:00Z" @default.